CJ Bioscience, Inc. (KOSDAQ:311690)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Biotechnology	3.47B	5.58B	4.07B	-	-
Biotechnology Growth	-37.82%	36.82%	-	-	-
NGS and Others	-	-	-	4.36B	-
Analyzes Biogene Information	-	-	-	-	5.31B
Analyzes Biogene Information Growth	-	-	-	-	11.05%
Total	3.47B	5.58B	4.07B	4.36B	5.31B
Total Growth	-37.82%	36.82%	-6.61%	-17.86%	11.05%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
South Korea	3.00B	4.15B	3.44B	4.09B	5.19B
South Korea Growth	-27.69%	20.69%	-15.88%	-21.27%	13.06%
Overseas	464.75M	529.21M	410.02M	273.93M	117.52M
Overseas Growth	-12.18%	29.07%	49.68%	133.10%	-37.92%
Total	3.47B	4.68B	3.85B	4.36B	5.31B
Total Growth	-25.94%	21.58%	-11.76%	-17.86%	11.05%

Source: S&P Global Market Intelligence.